Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Operating Expenses | 1,456 | 1,408 | 1,307 | 1,496 | 1,586 |
| Operating Income | -1,456 | -1,408 | -1,307 | -1,496 | -1,586 |
| Interest Expense | 0 | 9 | 0 | 0 | 0 |
| Other Income | 771 | 112 | 544 | 464 | 799 |
| Pre-tax Income | -686 | -1,305 | -763 | -1,032 | -788 |
| Income Tax | 2 | 8 | 21 | 39 | 97 |
| Net Income Continuous | -688 | -1,314 | -784 | -1,072 | -885 |
| Net Income | $-688 | $-1,314 | $-784 | $-1,072 | $-885 |
| EPS Basic Total Ops | -4.35 | -10.00 | -6.40 | -9.60 | 3.00 |
| EPS Basic Continuous Ops | -4.74 | -9.84 | -6.23 | -9.55 | 2.96 |
| EPS Diluted Total Ops | -4.35 | -10.00 | -6.40 | -9.60 | 3.00 |
| EPS Diluted Continuous Ops | -4.74 | -9.84 | -6.23 | -9.55 | 2.96 |
| EPS Diluted Before Non-Recurring Items | N/A | -10.00 | -6.40 | -9.60 | -4.40 |
| EBITDA(a) | $-1,454 | $-1,405 | $-1,304 | $-1,493 | $-1,584 |